Evaluate the Efficacy of the Treatment of Iatrogenic Subcutaneous Abdominal Wounds (ISAW) After Surgery by Application of Negative Pressure Wound Therapy (NPWT) in Comparison to Standard Conventional Wound Therapy (SCWT) of the Clinical Routine

NCT ID: NCT01611207

Last Updated: 2013-05-20

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

12 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether Negative Pressure Wound Therapy (NPWT) or Standard Conventional Wound Therapy (SCWT) are effective in the treatment of Iatrogenic Subcutaneous Abdominal Wound healing-impairments (ISAW).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the study is the comparison between NPWT and Standard Conventional Wound Therapy (SCWT) under clinical, safety and economic aspects in the treatment of postoperative Iatrogenic Subcutaneous Abdominal Wounds (ISAW). The hypothesis is based on the assumption that the application of NPWT for the treatment of postoperative abdominal wound healing impairments (with intact fascia) results in a decrease of time until achievement of wound closure (with confirmation after 30 consecutive days) and for this reason more wound closures can be achieved in the maximum treatment period of 42 days compared to the control therapy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Postoperative Abdominal Wounds Wound-healing Impairments

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Negative Pressure Wound Therapy

Used therapy systems

Group Type EXPERIMENTAL

Negative Pressure Wound Therapy

Intervention Type DEVICE

KCI. V.A.C. Freedom; Acti V.A.C.; INFO V.A.C. to be used with the V.A.C. Granufoam (black), V.A.C. Granufoam Silver and V.A.C. WhiteFoam Smith \& Nephew: Renasys GO and Renasys EZ Plus to be used with the Renassys-F/P and Renassys-G Use of the medical devices and applicable consumption items according to manufacturers guidelines and FDA regulations.

Standard Conventional Wound Therapy

Standard conventional wound therapy according to current evidence-based guideline (basic and advanced methods of wound treatment)

Group Type ACTIVE_COMPARATOR

Standard Wound Therapy

Intervention Type OTHER

Standard wound therapy according to current evidence-based guideline (basic and advanced methods of wound treatment)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Negative Pressure Wound Therapy

KCI. V.A.C. Freedom; Acti V.A.C.; INFO V.A.C. to be used with the V.A.C. Granufoam (black), V.A.C. Granufoam Silver and V.A.C. WhiteFoam Smith \& Nephew: Renasys GO and Renasys EZ Plus to be used with the Renassys-F/P and Renassys-G Use of the medical devices and applicable consumption items according to manufacturers guidelines and FDA regulations.

Intervention Type DEVICE

Standard Wound Therapy

Standard wound therapy according to current evidence-based guideline (basic and advanced methods of wound treatment)

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Vacuum assisted closure Vacuum assisted wound closure Standard Conventional Wound Therapy

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Acute subcutaneous abdominal wound-healing impairment after surgical intervention
* Sizes of wound opening (maximum diameter ≥ 3 cm)
* Wound surface ≥ 9 qcm

Exclusion Criteria

Lack of infrastructure for outpatient continuation of treatment and study-specific interventions

* Existence of an open abdominal fascia
* Acute serious organ failure
* Application of an other active vacuum device at the wound treated during the study conduct within 8 days before screening visit
* Ongoing / during 3 weeks after chemo therapy
* Ongoing / during 3 weeks after radiation therapy Contraindications in accordance with the safety precautions issued by the FDA or the companies
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kinetic Concepts, Inc.

INDUSTRY

Sponsor Role collaborator

Smith & Nephew Wound Management Inc

INDUSTRY

Sponsor Role collaborator

University of Witten/Herdecke

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Marcus Redaèlli

Administative and scientific head of staffed offices of Interdisciplinary Centre for Health Services Research

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Krankenhaus Martha-Maria Halle-Dölau

Halle, Saxony-Anhalt, Germany

Site Status

St. Marien-Krankenhaus Ahaus-Vrede

Ahaus, , Germany

Site Status

Asklepios Stadtklinik Bad Tölz GmbH

Bad Tölz, , Germany

Site Status

Bundeswehrkrankenhaus Berlin

Berlin, , Germany

Site Status

Klinikum Bilefeld - Mitte

Bielefeld, , Germany

Site Status

Knappschaftskrankenhaus Bochum der Ruhr

Bochum, , Germany

Site Status

Klinikum Darmstadt, Chirurgische Klinik III

Darmstadt, , Germany

Site Status

Diakonissenkrankenhaus Dessau /Roßlau

Dessau, , Germany

Site Status

Krankenhaus Düren gem. GmbH

Düren, , Germany

Site Status

Klinik für Gefäß- und Endovascular-Chirurgie, Klinikum der Johann Wolfgang Goethe - Universität

Frankfurt am Main, , Germany

Site Status

Krankenhaus St. Elisabeth und St. Barbara, Klinik für Allgmein- und Visceralchirurgie

Halle, , Germany

Site Status

Universitätsklinikum Halle/Saale, Allgemein-, Viszeral- und Gefäßchirurgie

Halle, , Germany

Site Status

Asklepios Westklinikum Hamburg

Hamburg, , Germany

Site Status

Sana Klinikum Hameln-Pyrmont Klinik für Allgemein- und Visceralchirurgie

Hamelin, , Germany

Site Status

Gemeinschaftskrankenhaus Herdecke

Herdecke, , Germany

Site Status

Universitätsklinikum Jena, Klinik für Allgemein-, Viszeral- und Gefäßchirurgie

Jena, , Germany

Site Status

Universitätsklinikum Jena, Klinik für Frauenheilkunde und Geburtshilfe, Abt. Gynäkologie

Jena, , Germany

Site Status

Westpfalz-Klinikum GmbH, Klinikum für Allgemein-, Viszeral- und Transplantationschirurgie

Kaiserslautern, , Germany

Site Status

Städtisches Klinikum Karlsruhe gGmbH, Klinik für Allgemein- und Viszeralchirurgie

Karlsruhe, , Germany

Site Status

Kliniken der Stadt Köln Krankenhaus Merheim, Klinik für Visceral-, Gefäß- und Transplantationschirurgie

Köln-Merheim, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein, Klinik für Chirurgie

Lübeck, , Germany

Site Status

Klinik und Poliklinik für Allgemein- und Abdominalchirurgie, Johannes Gutenberg- Universität

Mainz, , Germany

Site Status

Wundzentrum München

München, , Germany

Site Status

Klinikum der Universität München, Chirurgische Klinik und Poliklinik

München-Großhadern, , Germany

Site Status

Universitätsklinikum Münster, Klinik für Allgemein und Viszeralchirurgie

Münster, , Germany

Site Status

Städtisches Klinikum Neunkirchen

Neunkirchen/Saar, , Germany

Site Status

Ortenauklinikum Offenburg-Gengenbach

Offenburg, , Germany

Site Status

Klinikum Dorothea Christiane Erxleben

Quedlinburg, , Germany

Site Status

Carl-von-Basedow Klinikum, Saalekreis

Querfurt, , Germany

Site Status

Zentrum für Gefäßmedizin Klinikum Südstadt Rostock

Rostock, , Germany

Site Status

Asklepios Klinikum Uckermark GmbH, Klinik für Allgemein- und Visceralchirurgie

Schwedt, , Germany

Site Status

Agaplesion Bethesda-Krankenhaus Stuttgart

Stuttgart, , Germany

Site Status

HSK Dr. Horst Schmidt Kliniken

Wiesbaden, , Germany

Site Status

Evangelisches Krankenhaus Paul Gerhardt Stift, Allgemein-, Viszeral- und Gefäßchirurgie

Wittenberg, , Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

DRKS ID 00003498

Identifier Type: REGISTRY

Identifier Source: secondary_id

03-2012

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.